In silico Prediction and Pharmacokinetic Studies on Glucosinolates as a
Potential Drug and Key Inhibitor Molecule for Lanosterol-14α-
demethylase: A Fungal Membrane Biosynthesis Enzyme

Gurpreet      Singh

Abstract

Background: Glucosinolates (β-thioglucoside-N-hydroxysulfates) are a water-soluble organic anion with sulfur- and nitrogen-containing glycosides which are found in abundance in Cruciferous plants. Ergosterol (ERG13) lanosterol-14α-demethylase protein has been targeted for inhibition studies as a key regulator enzyme of fungal membrane biosynthesis.

Objectives: To understand the molecular mechanism of inhibition of Ergosterol (ERG13) lanosterol- 14α-demethylase by various phytochemicals from brassicales, i.e., glucosinolates and their potential role as putative drug molecules.

Methods: In this study, in silico analyses were performed to predict the molecular basis of various glucosinolates as a potential inhibitor of lanosterol-14α-demethylase protein, which is a key regulator of fungal membrane biosynthesis and its pharmacodynamics and toxicity profile. 3d structures of various glucosinolates were retrieved from PubChem, and the target protein, lanosterol-14α-demethylase (Pdb ID- 4lxj), was retrieved from the RCSB protein data bank. Molecular docking and interactions were carried out using the PyRx software using the AutoDOCK toolbar with default parameters. Dru- LiTo, ORISIS web servers were used to predict various drug likeliness predictions and Lipinski’s Rule of 5, whereas admetSAR was used for prediction of toxicity, and PASS Program was used to study the antifungal and antimicrobial properties of these compounds.

Results: This study shows that among the different compounds screened, gluconasturtiin, Glucotropaeolin, and Indolylmethyl-Glucosinolate showed the highest binding energies of -8.7 kcal/mol, -8.5 kcal/mol, and -8.3 kcal/mol with the lanosterol-14α-demethylase, respectively. Further all the compounds follow the Lipinski’s rule as well as they are found to be non-carcinogenic and non-cytotoxic in nature. These compounds also show antifungal properties.

Conclusion: This study thus reveals that various glucosinolates interact with the ERG13 enzyme at various amino acid positions, which behaves as a catalytic site, thus indicates the probable mechanism of inactivation, and subsequently, these can be used as potential drug molecules. In vitro studies can be taken to further examine the utility of these compounds as antifungal agents.

Keywords: Glucosinolates, lanosterol-14α-demethylase, ergosterol, pharmacokinetics and antifungal properties, molecular docking, sterols.

Graphical Abstract

[1]
Wollam J, Antebi A. Sterol regulation of metabolism, homeostasis, and development. Annu Rev Biochem  2011; 80(1): 885-916.
 [http://dx.doi.org/10.1146/annurev-biochem-081308-165917] [PMID: 21495846]

[2]
Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annu Rev Genet  2007; 41(1): 401-27.
 [http://dx.doi.org/10.1146/annurev.genet.41.110306.130315] [PMID: 17666007]

[3]
Parsi Z, Górecki T. Determination of ergosterol as an indicator of fungal biomass in various samples using non-discriminating flash pyrolysis. J Chromatogr A  2006; 1130(1): 145-50.
 [http://dx.doi.org/10.1016/j.chroma.2006.07.045]

[4]
Prasad R, Shah AH, Rawal MK. Antifungals: Mechanism of action and drug resistance. Adv Exp Med Biol  2016; 892: 327-49.
 [http://dx.doi.org/10.1007/978-3-319-25304-6_14] [PMID: 26721281]

[5]
Hughes AL, Lee CYS, Bien CM, Espenshade PJ. 4-Methyl sterols regulate fission yeast SREBP-Scap under low oxygen and cell stress. J Biol Chem  2007; 282(33): 24388-96.
 [http://dx.doi.org/10.1074/jbc.M701326200] [PMID: 17595166]

[6]
Zavrel M, Hoot SJ, White TC. Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae. Eukaryot Cell  2013; 12(5): 725-38.
 [http://dx.doi.org/10.1128/EC.00345-12] [PMID: 23475705]

[7]
Liu JF, Xia JJ, Nie KL, Wang F, Deng L. Outline of the biosynthesis and regulation of ergosterol in yeast. World J Microbiol Biotechnol  2019; 35(7): 98.
 [http://dx.doi.org/10.1007/s11274-019-2673-2] [PMID: 31222401]

[8]
Jordá T, Puig S. Regulation of ergosterol biosynthesis in Saccharomyces cerevisiae. Genes (Basel)  2020; 11(7): 795.
 [http://dx.doi.org/10.3390/genes11070795] [PMID: 32679672]

[9]
Polakowski T, Bastl R, Stahl U, Lang C. Enhanced sterol-acyl transferase activity promotes sterol accumulation in Saccharomyces cerevisiae. Appl Microbiol Biotechnol  1999; 53(1): 30-5.
 [http://dx.doi.org/10.1007/s002530051610] [PMID: 10645622]

[10]
Ploier B, Korber M, Schmidt C, Koch B, Leitner E, Daum G. Regulatory link between steryl ester formation and hydrolysis in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta  2015; 1851(7): 977-86.
 [http://dx.doi.org/10.1016/j.bbalip.2015.02.011] [PMID: 25720564]

[11]
Kalb VF, Woods CW, Turi TG, Dey CR, Sutter TR, Loper JC. Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae. DNA  1987; 6(6): 529-37.
 [http://dx.doi.org/10.1089/dna.1987.6.529] [PMID: 3322742]

[12]
Parker JE, Merkamm M, Manning NJ, Pompon D, Kelly SL, Kelly DE. Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 α-demethylase at the homologous locus. Antimicrob Agents Chemother  2008; 52(10): 3597-603.
 [http://dx.doi.org/10.1128/AAC.00517-08] [PMID: 18694951]

[13]
Anand U, Jacobo-Herrera N, Altemimi A, Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: Potential avenues of biocompatible drug discovery. Metabolites  2019; 9(11): 258.
 [http://dx.doi.org/10.3390/metabo9110258] [PMID: 31683833]

[14]
Ma W, Zhao Y, Wang Y. Withdrawn: Plant-derived tabersonine exert its antifungal activity by repressing the expression of ergosterol biosynthesis and cell wall mannoprotein encoding genes in Saccharomyces cerevisiae. Lett Appl Microbiol 2020.
 [http://dx.doi.org/10.1111/lam.13446]

[15]
Bvumbi C, Chi GF, Stevens MY, Mombeshora M, Mukanganyama S. The effects of tormentic acid and extracts from Callistemon citrinus on Candida albicans and Candida tropicalis growth and inhibition of ergosterol biosynthesis in Candida albicans. ScientificWorldJournal  2021; 2021: 8856147.
 [http://dx.doi.org/10.1155/2021/8856147] [PMID: 34594161]

[16]
Melrose J. The glucosinolates: A sulphur glucoside family of mustard anti-tumour and antimicrobial phytochemicals of potential therapeutic application. Biomedicines  2019; 7(3): 62.
 [http://dx.doi.org/10.3390/biomedicines7030062] [PMID: 31430999]

[17]
Tacer-Caba Z. Different Sources of Glucosinolates and their Derivatives. In: Galanakis CM, Ed. Glucosinolates: Properties, Recovery, and Applications.  Elsevier 2019; pp. 143-80.
 [http://dx.doi.org/10.1016/B978-0-12-816493-8.00005-6]

[18]
Griffiths DW, Birch ANE, Hillman JR. Antinutritional compounds in the Brassicaceae: Analysis, biosynthesis, chemistry and dietary effects. J Hortic Sci Biotechnol  1998; 73(1): 1-18.
 [http://dx.doi.org/10.1080/14620316.1998.11510937]

[19]
Aires A, Mota VR, Saavedra MJ, Rosa EAS, Bennett RN. The antimicrobial effects of glucosinolates and their respective enzymatic hydrolysis products on bacteria isolated from the human intestinal tract. J Appl Microbiol  2009; 106(6): 2086-95.
 [http://dx.doi.org/10.1111/j.1365-2672.2009.04180.x] [PMID: 19291240]

[20]
Royston KJ, Tollefsbol TO. The epigenetic impact of cruciferous vegetables on cancer prevention. Curr Pharmacol Rep  2015; 1(1): 46-51.
 [http://dx.doi.org/10.1007/s40495-014-0003-9] [PMID: 25774338]

[21]
Vig AP, Rampal G, Thind TS, Arora S. Bio-protective effects of glucosinolates - A review. Lebensm Wiss Technol  2009; 42(10): 1561-72.
 [http://dx.doi.org/10.1016/j.lwt.2009.05.023]

[22]
Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem  2010; 31(2): 455-61.
 [http://dx.doi.org/10.1002/jcc.21334] [PMID: 19499576]

[23]
Kim S, Chen J, Cheng T, et al. PubChem 2019 update: Improved access to chemical data. Nucleic Acids Res  2019; 47(D1): D1102-9.
 [http://dx.doi.org/10.1093/nar/gky1033] [PMID: 30371825]

[24]
Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol  2015; 1263: 243-50.
 [http://dx.doi.org/10.1007/978-1-4939-2269-7_19]

[25]
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev  2001; 46(1-3): 3-26.
 [http://dx.doi.org/10.1016/S0169-409X(00)00129-0] [PMID: 11259830]

[26]
Pangastuti A, Amin IF, Amin AZ, Amin M. Natural bioactive compound from moringa oleiferaagainst cancer based on in silico screening. J Teknol  2016; 78(5): 315-8.
 [http://dx.doi.org/10.11113/jt.v78.8328]

[27]
Yang H, Lou C, Sun L, et al. AdmetSAR 20: Web-Service for prediction and optimization of chemical ADMET properties. Bioinformatics  2019; 35: 1067-9.
 [http://dx.doi.org/10.1093/bioinformatics/bty707]

[28]
Poroikov V, Filimonov D, Lagunin A, Gloriozova T, Zakharov A. PASS: Identification of probable targets and mechanisms of toxicity. SAR QSAR Environ Res  2007; 18(1-2): 101-10.
 [http://dx.doi.org/10.1080/10629360601054032] [PMID: 17365962]

[29]
Goel RK, Singh D, Lagunin A, Poroikov V. PASS-assisted exploration of new therapeutic potential of natural products. Med Chem Res  2011; 20(9): 1509-14.
 [http://dx.doi.org/10.1007/s00044-010-9398-y]

[30]
Borges A, Abreu AC, Ferreira C, Saavedra MJ, Simões LC, Simões M. Antibacterial activity and mode of action of selected glucosinolate hydrolysis products against bacterial pathogens. J Food Sci Technol  2015; 52(8): 4737-48.
 [http://dx.doi.org/10.1007/s13197-014-1533-1] [PMID: 26243895]

[31]
Pastorczyk M, Bednarek P. The function of glucosinolates and related metabolites in plant innate immunity. Adv Bot Res  2016; 80: 171-98.
 [http://dx.doi.org/10.1016/bs.abr.2016.06.007]

[32]
Liu Z, Wang H, Xie J, et al. The roles of cruciferae glucosinolates in disease and pest resistance. Plants  2021; 10(6): 1097.
 [http://dx.doi.org/10.3390/plants10061097] [PMID: 34070720]

[33]
Plaszkó T, Szűcs Z, Vasas G, Gonda S. Effects of glucosinolate-derived isothiocyanates on fungi: A comprehensive review on direct effects, mechanisms, structure-activity relationship data and possible agricultural applications. J Fungi (Basel)  2021; 7(7): 539.
 [http://dx.doi.org/10.3390/jof7070539] [PMID: 34356918]

[34]
Flowers SA, Colón B, Whaley SG, Schuler MA, Rogers PD. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans. Antimicrob Agents Chemother  2015; 59(1): 450-60.
 [http://dx.doi.org/10.1128/AAC.03470-14] [PMID: 25385095]

[35]
Rampone S, Pagliarulo C, Marena C, et al. In silico analysis of the antimicrobial activity of phytochemicals: Towards a technological breakthrough. Comput Methods Programs Biomed  2021; 200: 105820.
 [http://dx.doi.org/10.1016/j.cmpb.2020.105820] [PMID: 33168272]

[36]
Prasanth DSNBK, Murahari M, Chandramohan V, Panda SP, Atmakuri LR, Guntupalli C. In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J Biomol Struct Dyn  2021; 39(13): 4618-32.
 [http://dx.doi.org/10.1080/07391102.2020.1779129] [PMID: 32567989]

[37]
Rolta R, Salaria D, Kumar V, et al. Molecular docking studies of phytocompounds of rheum emodi wall with proteins responsible for antibiotic resistance in bacterial and fungal pathogens: In silico approach to enhance the bio-availability of antibiotics. J Biomol Struct Dyn  2022; 40(8): 3789-803.
 [http://dx.doi.org/10.1080/07391102.2020.1850364]

[38]
Blake JF. Chemoinformatics - predicting the physicochemical properties of ‘drug-like’ molecules. Curr Opin Biotechnol  2000; 11(1): 104-7.
 [http://dx.doi.org/10.1016/S0958-1669(99)00062-2] [PMID: 10679344]

[39]
Srivastava V, Yadav A, Sarkar P. Molecular docking and ADMET study of bioactive compounds of Glycyrrhiza glabra against main protease of SARS-CoV2. Mater Today Proc  2022; 49: 2999-3007.
 [http://dx.doi.org/10.1016/j.matpr.2020.10.055] [PMID: 33078096]

[40]
Benigni R, Bossa C. Mechanisms of chemical carcinogenicity and mutagenicity: A review with implications for predictive toxicology. Chem Rev  2011; 111(4): 2507-36.
 [http://dx.doi.org/10.1021/cr100222q] [PMID: 21265518]

[41]
Liebler DC, Guengerich FP. Elucidating mechanisms of drug-induced toxicity. Nat Rev Drug Discov  2005; 4(5): 410-20.
 [http://dx.doi.org/10.1038/nrd1720] [PMID: 15864270]

Cite As

Current Drug Discovery Technologies

In silico Prediction and Pharmacokinetic Studies on Glucosinolates as a Potential Drug and Key Inhibitor Molecule for Lanosterol-14α- demethylase: A Fungal Membrane Biosynthesis Enzyme

Abstract

Graphical Abstract